Interferon Alpha-2: Pre-Clinical and Clinical Evaluation

Interferon alpha-2 is a genetically engineered, highly purified pharmaceutical agent that has undergone extensive phase I and phase II clinical study in more than 1000 patients. The material has biological activity by intravenous, intramus­ cular and subcutaneous routes. Clinical toxicity principally involves the ''influen­ za like'' syndrome previously seen with native interferons. Other importan...